Cargando…
Prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in European German‐speaking countries. Analysis of the APV initiative
BACKGROUND: Non‐alcoholic fatty liver disease (NAFLD), prediabetes and type 2 diabetes mellitus are known to be closely linked with obesity as early as during childhood. OBJECTIVES: The study aimed to determine the prevalence of prediabetes and T2DM in children with obesity with or without increased...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079233/ https://www.ncbi.nlm.nih.gov/pubmed/31810110 http://dx.doi.org/10.1111/ijpo.12601 |
_version_ | 1783507785942564864 |
---|---|
author | Koutny, Florian Weghuber, Daniel Bollow, E. Greber‐Platzer, S. Hartmann, K. Körner, A. Reinehr, T. Roebl, M. Simic‐Schleicher, G. Wabitsch, M. Widhalm, K. Wiegand, S. Holl, R. W. |
author_facet | Koutny, Florian Weghuber, Daniel Bollow, E. Greber‐Platzer, S. Hartmann, K. Körner, A. Reinehr, T. Roebl, M. Simic‐Schleicher, G. Wabitsch, M. Widhalm, K. Wiegand, S. Holl, R. W. |
author_sort | Koutny, Florian |
collection | PubMed |
description | BACKGROUND: Non‐alcoholic fatty liver disease (NAFLD), prediabetes and type 2 diabetes mellitus are known to be closely linked with obesity as early as during childhood. OBJECTIVES: The study aimed to determine the prevalence of prediabetes and T2DM in children with obesity with or without increased transaminases. METHODS: Data from the observational multicentre (n = 51), cross‐sectional Adipositas Patienten Verlaufsbeobachtung registry were analyzed. Mild increase (mild group) was defined by alanine transaminase (ALT) >24 to ≤50 U/L and moderate to severe increase (advanced group) by ALT > 50 U/L. Prediabetes and T2DM were defined according to recent IDF/ISPAD guidelines. RESULTS: The prevalence of prediabetes and T2DM was 11.9% (95% CI: 11.0–12.8) and 1.4% (95% CI: 1.1–1.7) among all participants (n = 4932; male = 2481; mean age 12.9 ± 2.7 years; BMI‐SDS 2.1 ± 0.5; Tanner stage 3.2 ± 1.5). The prevalence of impaired glucose metabolism (prediabetes and T2DM) was 13.8% (95% CI: 12.1–15.4) in the mild, 21.9% (95% CI: 18.8–25.1) in the advanced group, 10.7% (95% CI: 9.4–11.9) in the control group. Mild and advanced groups had greater odds ratios for prediabetes [1.42; 95% CI: 1.17–1.72, 2.26‐fold; (1.78–2.86), respectively], the advanced group also for T2DM [2.39 (1.36–4.21)] compared to controls. While an increase in transaminases predominantly affected boys, girls within the advanced group had a higher T2DM prevalence than males (5.4 vs. male 2.1%). CONCLUSIONS: Children with obesity and increased liver transaminases as surrogates of NAFLD should be screened for T2DM. |
format | Online Article Text |
id | pubmed-7079233 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70792332020-03-19 Prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in European German‐speaking countries. Analysis of the APV initiative Koutny, Florian Weghuber, Daniel Bollow, E. Greber‐Platzer, S. Hartmann, K. Körner, A. Reinehr, T. Roebl, M. Simic‐Schleicher, G. Wabitsch, M. Widhalm, K. Wiegand, S. Holl, R. W. Pediatr Obes Original Research BACKGROUND: Non‐alcoholic fatty liver disease (NAFLD), prediabetes and type 2 diabetes mellitus are known to be closely linked with obesity as early as during childhood. OBJECTIVES: The study aimed to determine the prevalence of prediabetes and T2DM in children with obesity with or without increased transaminases. METHODS: Data from the observational multicentre (n = 51), cross‐sectional Adipositas Patienten Verlaufsbeobachtung registry were analyzed. Mild increase (mild group) was defined by alanine transaminase (ALT) >24 to ≤50 U/L and moderate to severe increase (advanced group) by ALT > 50 U/L. Prediabetes and T2DM were defined according to recent IDF/ISPAD guidelines. RESULTS: The prevalence of prediabetes and T2DM was 11.9% (95% CI: 11.0–12.8) and 1.4% (95% CI: 1.1–1.7) among all participants (n = 4932; male = 2481; mean age 12.9 ± 2.7 years; BMI‐SDS 2.1 ± 0.5; Tanner stage 3.2 ± 1.5). The prevalence of impaired glucose metabolism (prediabetes and T2DM) was 13.8% (95% CI: 12.1–15.4) in the mild, 21.9% (95% CI: 18.8–25.1) in the advanced group, 10.7% (95% CI: 9.4–11.9) in the control group. Mild and advanced groups had greater odds ratios for prediabetes [1.42; 95% CI: 1.17–1.72, 2.26‐fold; (1.78–2.86), respectively], the advanced group also for T2DM [2.39 (1.36–4.21)] compared to controls. While an increase in transaminases predominantly affected boys, girls within the advanced group had a higher T2DM prevalence than males (5.4 vs. male 2.1%). CONCLUSIONS: Children with obesity and increased liver transaminases as surrogates of NAFLD should be screened for T2DM. John Wiley and Sons Inc. 2019-12-06 2020-04 /pmc/articles/PMC7079233/ /pubmed/31810110 http://dx.doi.org/10.1111/ijpo.12601 Text en © 2019 The Authors. Pediatric Obesity published by John Wiley & Sons Ltd on behalf of World Obesity Federation. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Research Koutny, Florian Weghuber, Daniel Bollow, E. Greber‐Platzer, S. Hartmann, K. Körner, A. Reinehr, T. Roebl, M. Simic‐Schleicher, G. Wabitsch, M. Widhalm, K. Wiegand, S. Holl, R. W. Prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in European German‐speaking countries. Analysis of the APV initiative |
title | Prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in European German‐speaking countries. Analysis of the APV initiative |
title_full | Prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in European German‐speaking countries. Analysis of the APV initiative |
title_fullStr | Prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in European German‐speaking countries. Analysis of the APV initiative |
title_full_unstemmed | Prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in European German‐speaking countries. Analysis of the APV initiative |
title_short | Prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in European German‐speaking countries. Analysis of the APV initiative |
title_sort | prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in european german‐speaking countries. analysis of the apv initiative |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079233/ https://www.ncbi.nlm.nih.gov/pubmed/31810110 http://dx.doi.org/10.1111/ijpo.12601 |
work_keys_str_mv | AT koutnyflorian prevalenceofprediabetesandtype2diabetesinchildrenwithobesityandincreasedtransaminasesineuropeangermanspeakingcountriesanalysisoftheapvinitiative AT weghuberdaniel prevalenceofprediabetesandtype2diabetesinchildrenwithobesityandincreasedtransaminasesineuropeangermanspeakingcountriesanalysisoftheapvinitiative AT bollowe prevalenceofprediabetesandtype2diabetesinchildrenwithobesityandincreasedtransaminasesineuropeangermanspeakingcountriesanalysisoftheapvinitiative AT greberplatzers prevalenceofprediabetesandtype2diabetesinchildrenwithobesityandincreasedtransaminasesineuropeangermanspeakingcountriesanalysisoftheapvinitiative AT hartmannk prevalenceofprediabetesandtype2diabetesinchildrenwithobesityandincreasedtransaminasesineuropeangermanspeakingcountriesanalysisoftheapvinitiative AT kornera prevalenceofprediabetesandtype2diabetesinchildrenwithobesityandincreasedtransaminasesineuropeangermanspeakingcountriesanalysisoftheapvinitiative AT reinehrt prevalenceofprediabetesandtype2diabetesinchildrenwithobesityandincreasedtransaminasesineuropeangermanspeakingcountriesanalysisoftheapvinitiative AT roeblm prevalenceofprediabetesandtype2diabetesinchildrenwithobesityandincreasedtransaminasesineuropeangermanspeakingcountriesanalysisoftheapvinitiative AT simicschleicherg prevalenceofprediabetesandtype2diabetesinchildrenwithobesityandincreasedtransaminasesineuropeangermanspeakingcountriesanalysisoftheapvinitiative AT wabitschm prevalenceofprediabetesandtype2diabetesinchildrenwithobesityandincreasedtransaminasesineuropeangermanspeakingcountriesanalysisoftheapvinitiative AT widhalmk prevalenceofprediabetesandtype2diabetesinchildrenwithobesityandincreasedtransaminasesineuropeangermanspeakingcountriesanalysisoftheapvinitiative AT wiegands prevalenceofprediabetesandtype2diabetesinchildrenwithobesityandincreasedtransaminasesineuropeangermanspeakingcountriesanalysisoftheapvinitiative AT hollrw prevalenceofprediabetesandtype2diabetesinchildrenwithobesityandincreasedtransaminasesineuropeangermanspeakingcountriesanalysisoftheapvinitiative |